Varex Imaging (VI4) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VI4 Analyst Ratings

Hold

0 Buy

4 Hold

0 Sell

Based on 4 analysts giving stock ratings to

Varex

Imaging

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VI4 Stock 12 Month Forecast

Average Price Target

€16.41

▲(4.53% Upside)

Based on 4 Wall Street analysts offering 12 month price targets for Varex Imaging in the last 3 months. The average price target is €16.41 with a high forecast of €16.48 and a low forecast of €16.39. The average price target represents a 4.53% change from the last price of €15.70.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"€7","12":"€12","17":"€17","9.5":"€9.5","14.5":"€14.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16.47546449,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€16.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.41042976175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€16.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.388751519,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€16.39</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,9.5,12,14.5,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.7,15.759651114615384,15.819302229230768,15.878953343846153,15.938604458461539,15.998255573076923,16.057906687692306,16.117557802307694,16.177208916923078,16.236860031538463,16.296511146153847,16.35616226076923,16.415813375384616,{"y":16.47546449,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.7,15.754648443211538,15.809296886423077,15.863945329634614,15.918593772846153,15.973242216057692,16.02789065926923,16.08253910248077,16.137187545692306,16.191835988903843,16.246484432115384,16.30113287532692,16.35578131853846,{"y":16.41042976175,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.7,15.752980886076923,15.805961772153845,15.858942658230768,15.911923544307692,15.964904430384614,16.017885316461538,16.07086620253846,16.123847088615385,16.17682797469231,16.22980886076923,16.282789746846152,16.335770632923076,{"y":16.388751519,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.7,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.65,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.95,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.3,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.15,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.3,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.7,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.95,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.6,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":15.7,"date":1788220800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€16.48

Average Price Target€16.41

Lowest Price Target€16.39

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lawrence Solow

CJS Securities

€16.39

Hold

4.39%

Upside

Downgraded

08/17/26

Varex Imaging downgraded to Market Perform from Outperform at CJS SecuritiesVarex Imaging downgraded to Market Perform from Outperform at CJS Securities

Suraj Kalia

Oppenheimer

€15.61→€16.39

Hold

4.39%

Upside

Downgraded

08/11/26

Varex Imaging downgraded to Perform from Outperform at OppenheimerVarex Imaging downgraded to Perform from Outperform at Oppenheimer

Anderson Schock

B. Riley Securities

€15.61→€16.39

Hold

4.39%

Upside

Downgraded

08/10/26

Varex Imaging downgraded to Neutral from Buy at B. RileyVarex Imaging downgraded to Neutral from Buy at B. Riley

James Sidoti

Sidoti

€16.48

Hold

4.94%

Upside

Downgraded

08/10/26

Varex Imaging downgraded to Neutral from Buy at SidotiVarex Imaging downgraded to Neutral from Buy at Sidoti

Matthew Taylor

Jefferies

€8.67→€10.41

Hold

-33.72%

Downside

Reiterated

10/03/25

Varex Imaging (VREX) Receives a Hold from Jefferies

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lawrence Solow

CJS Securities

€16.39

Hold

4.39%

Upside

Downgraded

08/17/26

Varex Imaging downgraded to Market Perform from Outperform at CJS SecuritiesVarex Imaging downgraded to Market Perform from Outperform at CJS Securities

Suraj Kalia

Oppenheimer

€15.61→€16.39

Hold

4.39%

Upside

Downgraded

08/11/26

Varex Imaging downgraded to Perform from Outperform at OppenheimerVarex Imaging downgraded to Perform from Outperform at Oppenheimer

Anderson Schock

B. Riley Securities

€15.61→€16.39

Hold

4.39%

Upside

Downgraded

08/10/26

Varex Imaging downgraded to Neutral from Buy at B. RileyVarex Imaging downgraded to Neutral from Buy at B. Riley

James Sidoti

Sidoti

€16.48

Hold

4.94%

Upside

Downgraded

08/10/26

Varex Imaging downgraded to Neutral from Buy at SidotiVarex Imaging downgraded to Neutral from Buy at Sidoti

Matthew Taylor

Jefferies

€8.67→€10.41

Hold

-33.72%

Downside

Reiterated

10/03/25

Varex Imaging (VREX) Receives a Hold from Jefferies

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ARWRArrowhead Pharmaceuticals

PTGXProtagonist Therapeutics

ESTAEstablishment Labs Holdings

ZVRAZevra Therapeutics

IMUXImmunic

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Varex Imaging

3 Months

Google Medical - DevicesTipRanks - Google

Success Rate

0/1 ratings generated profit

Average Return

-0.60%

Copying Google Medical - Devices's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -0.60% per trade.

1 Year

Google Medical - DevicesTipRanks - Google

Success Rate

0/1 ratings generated profit

Average Return

-0.60%

Copying Google Medical - Devices's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -0.60% per trade.

2 Years

Google Medical - DevicesTipRanks - Google

Success Rate

0/1 ratings generated profit

Average Return

-0.60%

Copying Google Medical - Devices's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -0.60% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VI4 Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, VI4 has received 0 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. VI4 average Analyst price target in the past 3 months is 16.41.

Each month's total comprises the sum of three months' worth of ratings.

VI4 Financial Forecast

VI4 Earnings Forecast

Next quarter’s earnings estimate for VI4 is €0.25 with a range of €0.21 to €0.28. The previous quarter’s EPS was €0.27. VI4 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year VI4 has Performed in-line its overall industry.

VI4 Sales Forecast

Next quarter’s sales forecast for VI4 is €197.52M with a range of €195.10M to €200.02M. The previous quarter’s sales results were €180.94M. VI4 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year VI4 has Performed in-line its overall industry.

VI4 Stock Forecast FAQ

What is DE:VI4’s average 12-month price target, according to analysts?

Based on analyst ratings, Varex Imaging Corporation’s 12-month average price target is 16.41.

What is DE:VI4’s upside potential, based on the analysts’ average price target?

Varex Imaging Corporation has 4.53% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Varex Imaging Corporation a Buy, Sell or Hold?

Varex Imaging Corporation has a consensus rating of Hold, which is based on 0 buy ratings, 4 hold ratings and 0 sell ratings.

What is Varex Imaging Corporation’s share price target?

The average share price target for Varex Imaging Corporation is 16.41. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €16.48 ,and the lowest forecast is €16.39. The average share price target represents 4.53% Increase from the current price of €15.7.

What do analysts say about Varex Imaging Corporation?

Varex Imaging Corporation’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of Varex Imaging Corporation?

To buy shares of DE:VI4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Varex Imaging (VI4) Stock Forecast & Price Target

VI4 Analyst Ratings

VI4 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Varex Imaging

VI4 Analyst Recommendation Trends

VI4 Financial Forecast

VI4 Earnings Forecast

VI4 Sales Forecast

VI4 Stock Forecast FAQ

Detailed List of Analyst Forecasts